about
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitineBusulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthaseDynamics of fat cell turnover in humansBiodistribution, kinetics, and biological fate of SPION microbubbles in the rat.Real-time assessment of tissue hypoxia in vivo with combined photoacoustics and high-frequency ultrasound.Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseActivation of Wnt/β-catenin pathway in monocytes derived from chronic kidney disease patientsPharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice.Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus.Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.Fluorescence labeled microbubbles for multimodal imaging.DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line.Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies.G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield.Inhibition of proteasome deubiquitinating activity as a new cancer therapy.A pharmacodynamic study of 5-azacytidine in the P39 cell line.Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response.Infection-associated hemophagocytic syndrome complicated by infectious lymphoproliferation: a case report.Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line.Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.Myeloablative and immunosuppressive properties of treosulfan in mice.Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis.Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis.Hematologic malignancies in elderly patients.Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib.Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.Gas chromatographic-mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine.Simple method based on fluorescent detection for the determination of 4-hydroxycyclophosphamide in plasma.Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin.Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion.
P50
Q27652149-0FEAC089-4E0A-4905-BC6D-D33C1AC8BF24Q28732371-828D5E38-722A-46BB-B4C8-ABAD575C0836Q29615688-45DA1A80-E92A-46DA-B7AF-A581A41338CDQ30449495-8CCFF6C6-B082-443B-9AE4-1A9CED48E89BQ30575811-0272C058-A189-4029-BF37-0A2292F1BDB8Q34443622-51D0AC47-47CC-41F0-94DD-1957379831C0Q34508425-5C33E976-EE5C-4D78-B24C-FEC95CF80A0BQ34673038-14B55350-D777-41F3-A169-DA990884E883Q34918828-8083EE83-6806-44C6-A008-5398FC01A0CBQ35002296-3330FE21-3708-41A7-8B2F-FC091527B4A3Q37505854-0740CBAE-E8AF-4258-A381-D149DFD93A25Q37517571-4873207B-ED86-481D-A48D-8EBB06E68F25Q38068541-C662C7FD-AE26-4CD5-B4B7-65EA3B8394A3Q38552636-9525B6F1-360F-4EEB-809B-E3224B90BCAAQ38748866-93C813B6-FF91-49CC-8D70-EA0469A4D60AQ38851699-B56D6599-FB67-4B4E-A8D5-A84A95DDE3E7Q38869871-C0BEC36D-0676-42CE-838F-5160171204BEQ38915625-CB7562E0-0ADF-430C-93D1-5E6F0939E232Q38921804-828D3B88-DB19-4C66-9D25-4A84377E262EQ39013204-5BC24369-602C-4931-A1FD-16917A52AC9DQ39447379-9EB6FB55-9E56-4DD4-82BC-3C2902802D7FQ40329694-42CE641F-5476-4281-889E-C253459656E9Q40575462-5C523BA1-FE28-4378-84C4-10D6B443929DQ40671517-5EECB182-AD82-4507-8C92-B23751404FB4Q40712208-44665749-072C-499B-A740-0A36D5370CC6Q41064335-BE9DFDA0-AF13-48FC-AA31-3A76CEC27183Q41886285-13B29DDC-3F4E-4FC3-8108-18A1263B098FQ42168522-9B43ABF8-2B59-4FF1-B323-3E0672FD3238Q42351682-40B56E68-C1ED-4F9E-9EFB-3571648EE777Q42712639-057A2492-1E69-4C97-A7FB-5A6F19DDD29EQ42713818-7431C719-200F-4B19-8967-DEE070FE1790Q42716194-4371C688-8704-418A-8201-65285E8A6FDAQ43280937-CFC680BC-2AAE-40CE-863A-204A113F93F6Q43640569-4894CECE-726A-446C-B22F-25DCA393C951Q43682545-43D961AC-B517-4B41-831D-5EB1D7A2748CQ43703898-19D44D5F-544B-4BA8-A394-B48D12254E2EQ44000973-79D0B8EE-2BB2-42E9-ABAC-C273839E84C0Q44351300-13B53DE8-3649-4117-84AC-053247D87E77Q44396463-3AD989EA-F0AC-445C-AF74-6414C16A86CAQ44598815-A64E465C-AF83-4CBD-8595-F73B26AA01B4
P50
description
onderzoeker
@nl
professor at Karolinska Institutet
@en
professor vid Karolinska Institutet
@sv
name
Moustapha Hassan
@ast
Moustapha Hassan
@en
Moustapha Hassan
@es
Moustapha Hassan
@nl
Moustapha Hassan
@sl
Moustapha Hassan
@sv
type
label
Moustapha Hassan
@ast
Moustapha Hassan
@en
Moustapha Hassan
@es
Moustapha Hassan
@nl
Moustapha Hassan
@sl
Moustapha Hassan
@sv
prefLabel
Moustapha Hassan
@ast
Moustapha Hassan
@en
Moustapha Hassan
@es
Moustapha Hassan
@nl
Moustapha Hassan
@sl
Moustapha Hassan
@sv
P1053
H-9260-2015
P106
P1556
hassan.moustapha
P1651
gCHcCFyWO6s
P2038
Moustapha_Hassan
P21
P31
P3829
P496
0000-0003-1927-5859